SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001085037-23-000025
Filing Date
2023-02-23
Accepted
2023-02-23 11:42:08
Documents
9
Period of Report
2023-02-23

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k013123.htm 6-K 8538
2 EXHIBIT 99.1 - NEWS RELEASE ex99_1.htm EX-99.1 10499
3 EXHIBIT 99.2 - NEWS RELEASE ex99_2.htm EX-99.2 9272
4 EXHIBIT 99.3 - MATERIAL CHANGE REPORT ex99_3.htm EX-99.3 72169
5 EXHIBIT 99.4 - NEWS RELEASE ex99_4.htm EX-99.4 14104
6 EXHIBIT 99.5 - MATERIAL CHANGE REPORT ex99_5.htm EX-99.5 5354
7 image00001.jpg GRAPHIC 3318
8 image00003.jpg GRAPHIC 4679
9 image00004.jpg GRAPHIC 2545
  Complete submission text file 0001085037-23-000025.txt   136144
Mailing Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1
Business Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1 604-248-8693
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-50112 | Film No.: 23657777
SIC: 2836 Biological Products, (No Diagnostic Substances)